Compliance with oral drug therapy in patients with hematologic malignancy. 1987

A M Levine, and J L Richardson, and G Marks, and K Chan, and J Graham, and J N Selser, and C Kishbaugh, and D R Shelton, and C A Johnson

Compliance with oral self-administered allopurinol (daily medication) and prednisone (intermittent medication) as well as compliance with monthly scheduled clinic appointments, were examined in 108 patients with newly diagnosed hematologic malignancy. Baseline levels of compliance (control group) were compared to results obtained after implementation of three intervention packages, whose aim was to increase compliance. The packages included combinations of education, home psychologic support and restructuring, and training in pill taking. A 24-hour profile of the two drugs and their metabolites was first determined. Serum samples were then obtained monthly over 6 months and analyzed for presence of the drugs. Control patients were fully compliant with allopurinol only 16.8% of the time. This rate increased significantly (44% to 48% of the time) for those who received any one of the intervention programs. With respect to prednisone, control patients were compliant 26.8% of the time, with no real improvement after interventions. Finally, self reports overestimated compliance by a factor of two when compared to drug analysis. The results indicated that full compliance with oral medications was remarkably low among our patients who have treatable and in some cases curable hematologic malignancy. However, compliance can be significantly improved by the use of various intervention packages.

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010349 Patient Compliance Voluntary cooperation of the patient in following a prescribed regimen. Client Adherence,Client Compliance,Non-Adherent Patient,Patient Adherence,Patient Cooperation,Patient Noncompliance,Patient Non-Adherence,Patient Non-Compliance,Patient Nonadherence,Therapeutic Compliance,Treatment Compliance,Adherence, Client,Adherence, Patient,Client Compliances,Compliance, Client,Compliance, Patient,Compliance, Therapeutic,Compliance, Treatment,Cooperation, Patient,Non Adherent Patient,Non-Adherence, Patient,Non-Adherent Patients,Non-Compliance, Patient,Nonadherence, Patient,Noncompliance, Patient,Patient Non Adherence,Patient Non Compliance,Patient, Non-Adherent,Therapeutic Compliances,Treatment Compliances
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

A M Levine, and J L Richardson, and G Marks, and K Chan, and J Graham, and J N Selser, and C Kishbaugh, and D R Shelton, and C A Johnson
March 1996, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
A M Levine, and J L Richardson, and G Marks, and K Chan, and J Graham, and J N Selser, and C Kishbaugh, and D R Shelton, and C A Johnson
December 2017, Journal de mycologie medicale,
A M Levine, and J L Richardson, and G Marks, and K Chan, and J Graham, and J N Selser, and C Kishbaugh, and D R Shelton, and C A Johnson
May 1995, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics,
A M Levine, and J L Richardson, and G Marks, and K Chan, and J Graham, and J N Selser, and C Kishbaugh, and D R Shelton, and C A Johnson
July 2022, The Annals of thoracic surgery,
A M Levine, and J L Richardson, and G Marks, and K Chan, and J Graham, and J N Selser, and C Kishbaugh, and D R Shelton, and C A Johnson
July 2022, Blood,
A M Levine, and J L Richardson, and G Marks, and K Chan, and J Graham, and J N Selser, and C Kishbaugh, and D R Shelton, and C A Johnson
April 1977, International surgery,
A M Levine, and J L Richardson, and G Marks, and K Chan, and J Graham, and J N Selser, and C Kishbaugh, and D R Shelton, and C A Johnson
January 2017, Journal of intensive care medicine,
A M Levine, and J L Richardson, and G Marks, and K Chan, and J Graham, and J N Selser, and C Kishbaugh, and D R Shelton, and C A Johnson
January 1980, Archives of internal medicine,
A M Levine, and J L Richardson, and G Marks, and K Chan, and J Graham, and J N Selser, and C Kishbaugh, and D R Shelton, and C A Johnson
June 1982, Epilepsia,
A M Levine, and J L Richardson, and G Marks, and K Chan, and J Graham, and J N Selser, and C Kishbaugh, and D R Shelton, and C A Johnson
November 1991, British journal of clinical pharmacology,
Copied contents to your clipboard!